Drug Shortage Report for ALKERAN
| Report ID | 118933 |
| Drug Identification Number | 02087286 |
| Brand name | ALKERAN |
| Common or Proper name | Alkeran Injection / Melphalan |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | MELPHALAN BUFFER SOLUTION |
| Strength(s) | 50MG 10ML |
| Dosage form(s) | KIT POWDER FOR SOLUTION SOLUTION |
| Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS |
| Packaging size | 1 vial |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-30 |
| Estimated end date | 2021-12-01 |
| Actual end date | 2021-11-04 |
| Shortage status | Resolved |
| Updated date | 2021-11-05 |
| Company comments | GR80016CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v29 | 2021-11-05 | English | Compare |
| v28 | 2021-11-04 | French | Compare |
| v27 | 2021-11-04 | English | Compare |
| v26 | 2021-09-28 | French | Compare |
| v25 | 2021-09-28 | English | Compare |
| v24 | 2021-09-28 | French | Compare |
| v23 | 2021-09-28 | English | Compare |
| v22 | 2021-09-14 | French | Compare |
| v21 | 2021-09-14 | English | Compare |
| v20 | 2021-09-14 | French | Compare |
| v19 | 2021-09-14 | English | Compare |
| v18 | 2021-09-14 | English | Compare |
| v17 | 2021-09-03 | French | Compare |
| v16 | 2021-09-03 | English | Compare |
| v15 | 2021-05-01 | English | Compare |
| v14 | 2021-03-24 | French | Compare |
| v13 | 2021-03-24 | English | Compare |
| v12 | 2021-03-24 | French | Compare |
| v11 | 2021-03-24 | English | Compare |
| v10 | 2021-02-02 | English | Compare |